Retrovirally expressed anti-HIV ribozymes confer a selective survival advantage on CD4+ T cells in vitro (Q45865707)
scientific article published in March 2000
Language:
(P31) (Q13442814)
(P50) (Q39749891)
(P304) 408-416
(P433) 5
(P478) 7
(P577) Wednesday, March 1, 2000
(P1433) (Q15763095)
(P1476) "Retrovirally expressed anti-HIV ribozymes confer a selective survival advantage on CD4+ T cells in vitro" (language: en)
(P2093) Klebba C
Scherr M
Pape M
Engels JW
Grez M
Hoelzer D
Klein SA
(P2860) (Q54719925)
(Q37298055)
(Q35285900)
(Q41068471)
(Q39177405)
(Q35298890)
(Q41381214)
(Q41028945)
(Q41429788)
(Q44845726)
(Q29547822)
(Q41428894)
(Q40884585)
(Q41203517)
(Q41603934)
(Q38363343)
(Q41245271)
(Q29547802)
(Q25938986)
(Q45777682)
(Q36747388)
other details
description scientific article published in March 2000

External Links